These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4155757)

  • 1. Antagonistic effects of neuroleptics and apomorphine on synaptosomal tyrosine hydroxylase in vitro.
    Christiansen J; Squires RF
    J Pharm Pharmacol; 1974 Sep; 26(9):742-3. PubMed ID: 4155757
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of butaclamol and of other neuroleptic agents on the apomorphine-elicited inhibition of synaptosomal tyrosine hydroxylase activity.
    Bronaugh RL; Tabak J; Ohashi T; Goldstein M
    Psychopharmacol Commun; 1975; 1(5):501-10. PubMed ID: 7003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonistic effects of apomorphine and haloperidol on rat striatal synaptosomal tyrosine hydroxylase.
    Christiansen J; Squires RF
    J Pharm Pharmacol; 1974 May; 26(5):367-9. PubMed ID: 4152779
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of various chlorpromazine derivatives on the apomorphine-elicited inhibition of synaptosomal tyrosine hydroxylase activity.
    Bronaugh RL; Goldstein M
    Psychopharmacol Commun; 1975; 1(2):201-8. PubMed ID: 4859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pertussis toxin on inhibition of synaptosomal tyrosine hydroxylase activity by apomorphine.
    Harada K; Meller E; Goldstein M
    Eur J Pharmacol; 1990 Mar; 188(2-3):123-8. PubMed ID: 1969353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of dopamine and of apomorphine on dB-cAMP induced stimulation of synaptosomal tyrosine hydroxylase.
    Ebstein B; Roberge C; Tabachnick J; Goldstein M
    J Pharm Pharmacol; 1974 Dec; 26(12):975-7. PubMed ID: 4156865
    [No Abstract]   [Full Text] [Related]  

  • 7. Presynaptic dopamine and serotonin receptors modulating tyrosine hydroxylase activity in synaptosomes of the nucleus accumbens of rats.
    Hetey L; Kudrin VS; Shemanow AY; Rayevsky KS; Oelssner W
    Eur J Pharmacol; 1985 Jul; 113(1):1-10. PubMed ID: 2864259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of neuroleptics on tyrosine hydroxylase from rat hypothalamus synaptosomes].
    Mineeva-Vialykh MF; Raevskiĭ KS
    Biull Eksp Biol Med; 1976; 81(4):434-6. PubMed ID: 6100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dopaminephilic agents and cAMP on tyrosine hydroxylase activity.
    Goldstein M; Bronaugh RL; Lew JU; Ohashi T; Drummond GS; Fuxe K
    Adv Biochem Psychopharmacol; 1977; 16():447-53. PubMed ID: 18892
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction of apomorphine, neuroleptics and stimulants with alpha-methyl-m-tyramine, a false dopaminergic transmitter.
    Dorris RL; Shore PA
    Biochem Pharmacol; 1974 Feb; 23(4):867-72. PubMed ID: 4150986
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes of kinetic constant of striatal tyrosine hydroxylase elicited by neuroleptics that impair the function of dopamine receptors.
    Zivkovic B; Guidotti A
    Brain Res; 1974 Oct; 79(3):505-9. PubMed ID: 4153770
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of catecholamine releasing agents on synaptosomal dopamine biosynthesis: multiple pools of dopamine or multiple forms of tyrosine hydroxylase.
    Kuczenski R
    Neuropharmacology; 1975 Jan; 14(1):1-10. PubMed ID: 239360
    [No Abstract]   [Full Text] [Related]  

  • 13. Stimulation of tyrosine hydroxylase activity by cyclic AMP in synaptosomes and in soluble striatal enzyme preparations.
    Goldstein M; Bronaugh RL; Ebstein B; Roberge C
    Brain Res; 1976 Jun; 109(3):563-74. PubMed ID: 6124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central catecholamine neurons, behavior and neuroleptic drugs: an analysis to understand the involvement of catecholamines in schizophrenia.
    Fuxe K; Nyström M; Tovi M; Smith R; Ogren SO
    J Psychiatr Res; 1974; 11():151-61. PubMed ID: 4156786
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of apomorphine and pimozide on synthesis and turnover of labelled catecholamines in mouse brain.
    Nybäck H; Schubert J; Sedvall G
    J Pharm Pharmacol; 1970 Aug; 22(8):622-4. PubMed ID: 4394540
    [No Abstract]   [Full Text] [Related]  

  • 16. Striatal synaptosomal tyrosine hydroxylase activity. A model system for study of presynaptic dopamine receptors.
    McMillen BA
    Biochem Pharmacol; 1982 Aug; 31(16):2643-7. PubMed ID: 6128002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory mechanisms of dopamine biosynthesis at the tyrosine hydroxylase step.
    Goldstein M
    Ann N Y Acad Sci; 1984; 430():1-5. PubMed ID: 6146282
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of some psychotropic drugs on tyrosine hydroxylase activity in different structures of the rat brain.
    Besson MJ; Cheramy A; Gauchy C; Musacchio J
    Eur J Pharmacol; 1973 May; 22(2):181-6. PubMed ID: 4146008
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopamine autoreceptor regulation of the kinetic state of striatal tyrosine hydroxylase.
    Strait KA; Kuczenski R
    Mol Pharmacol; 1986 Jun; 29(6):561-9. PubMed ID: 2872588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of tyrosine hydroxylase but not dopamine-beta-hydroxylase facilitates the action of behaviourally ineffective doses of neuroleptics.
    Antelman SM; Szechtman H; Chin P; Fisher AE
    J Pharm Pharmacol; 1976 Jan; 28(1):66-8. PubMed ID: 6656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.